Location History:
- Anyang-si, KR (2018)
- Seoul, KR (2018 - 2021)
Company Filing History:
Years Active: 2018-2021
Title: Ho Bin Kim: Innovator in Stem Cell Research
Introduction
Ho Bin Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of stem cell research, holding a total of 9 patents. His work focuses on innovative methods for producing and differentiating induced pluripotent stem cells, which have important implications for regenerative medicine.
Latest Patents
One of his latest patents is a method of making human cells expressing OCT4, SOX2, and Nanog using an Ecklonia cava extract. This patent describes a medium composition for reprogramming induced pluripotent stem cells, which includes an Ecklonia cava extract. The method allows for the efficient production of induced pluripotent stem cells from adipose-derived mesenchymal stem cells, ensuring safety and ease of use. The pluripotent stem cells produced can differentiate into various cell types, making them suitable for use as cell therapeutic agents. Another notable patent involves a method for differentiating a pluripotent stem cell induced from a mesenchymal stem cell into an adipocyte. This invention also relates to a medium composition that facilitates dedifferentiation into induced pluripotent stem cells.
Career Highlights
Throughout his career, Ho Bin Kim has worked with various organizations, including Bbhc Co., Ltd. and Bbhc. His innovative approaches and research have positioned him as a key figure in the advancement of stem cell technology.
Collaborations
Ho Bin Kim has collaborated with notable colleagues, including Sang Yeon Lee and Won Ju Jung. Their combined expertise has contributed to the success of their research endeavors.
Conclusion
Ho Bin Kim's work in stem cell research exemplifies the potential of innovative methods in regenerative medicine. His patents and collaborations highlight his commitment to advancing the field and improving therapeutic options for patients.